Frontlight ResearchEarly access
CompletedNo phase
Healing at Home 2.0 - Enhanced Chat Tool for Lowering Postpartum Depression
Key facts
- Who runs it
- University of Pennsylvania
- Where
- Philadelphia, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 156 people enrolled
- Started
- 13 Mar 2025
- Ended
- 18 Aug 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- Healing @ Home Program (H@H 2.0)
- Record updated
- 3 September 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Postpartum patients who have delivered a singleton baby at or after 37w0d at the Hospital of the University of Pennsylvania
- Self-identify as a person of color (listed on chart as non-White race and confirmed with patient)
- Able to speak, read and write English
- Age ≥18
- Prenatal care at outpatient practice affiliated with the Hospital of the University of Pennsylvania
- Completion of clinically administered EPDS during inpatient stay
- Routine discharge timing, day 2 or more after vaginal delivery, day 3 or more after cesarean delivery
Who cannot take part
- Unable to provide informed consent
- Baby not discharged with mother at postpartum discharge
- Does not have access to a mobile phone
Where in United States
- Hospital of the University of PennsylvaniaPhiladelphia, United States
About the trial
What the trial wants to find out
The purpose of the study is to determine if access to a text-message based holistic chatbot support program "Healing at Home 2.0" decreases depressive symptoms as measured by the Edinburgh Postnatal Depression Scale (EPDS) compared to usual postpartum care for patients of color.
The 2 groups in the trial
- Standard of careNo study treatment, for comparison
Routine postpartum care.
- Healing @ Home Program (H@H 2.0)Treatment being tested
Routine postpartum care and the use of an algorithm-based text message support program for six weeks.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 3 September 2026